1 Nichols JH, Christenson RH, Clarke W, et al. Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing[J]. Clin Chim Acta, 2007, 379(1-2): 14-28.
10 Nydegger U. Transfusion dependency of cardiac surgery-update 2006[J]. Swiss Med Wkly, 2006, 136(49/50): 781-788.
[11]
11 Bertrand OF, Rodés-Cabau J, Rinfret S, et al. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy[J]. Am J Cardiol, 2009, 104(9): 1235-1240.
[12]
12 Kendall J, Reeves B, Clancy M. Point of care testing: randomised controlled trial of clinical outcome[J]. Br Med J, 1998, 316(7137): 1052-1057.
[13]
13 Urwyler N, Staub LP, Beran D, et al. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test[J]. Thromb Haemost, 2009, 102(4): 779-786.
16 Spalding GJ, Hartrumpf M, Sierig T, et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of “bedside” thrombelastography (ROTEM)[J]. Eur J Cardiothorac Surg, 2007, 31(6): 1052-1057.
[17]
17 Urwyler N, Trelle S, Theiler L, et al. Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery The POC-OP randomized-controlled trial[J]. Trials, 2009, 10: 107.
19 Sokoll LJ, Wians FH, Remaley AT. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing[J]. Clin Chem, 2004, 50(7): 1126-1135.
